Jagsonpal Pharmaceuticals Ltd Q3 FY2024-25 net profit jumps to Rs. 31.99 crores

has reported Standalone financial results for the period ended December 31, 2024.

Financial Results (Q3 FY2025) - QoQ Comparison

The company has reported total income of Rs. 76.347 crores during the period ended December 31, 2024 as compared to Rs. 76.346 crores during the period ended September 30, 2024.

The company has posted net profit / (loss) of Rs. 31.990 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs. 11.459 crores for the period ended September 30, 2024.

The company has reported EPS of Rs. 4.74 for the period ended December 31, 2024 as compared to Rs. 1.70 for the period ended September 30, 2024.

Financials	Q3 FY2025	Q2 FY2025	% Change
Total Income	₹ 76.347 crs	₹76.346 crs	0.00%
Net Profit	₹31.990 crs	₹11.459 crs	179.17%
EPS	₹4.74	₹1.70	178.82%

Financial Results (Q3 FY2025) - YoY Comparison

The company has reported total income of Rs. 76.347 crores during the period ended December 31, 2024 as compared to Rs.49.755 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs.31.990 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs.3.963 crores for the period ended December 31, 2023.

The company has reported EPS of Rs.4.74 for the period ended December 31, 2024 as compared to Rs.0.59 for the period ended December 31, 2023.

Financials	Q3 FY2025	Q3 FY2024	% Change
Total Income	₹ 76.347 crs	₹49.755 crs	53.45%
Net Profit	₹31.990 crs	₹3.963 crs	707.22%
EPS	₹4.74	₹0.59	703.39%

Financial Results (9 Months Ended FY2025) - YoY Comparison

The company has reported total income of Rs.215.576 crores during the 9 Months period ended December 31, 2024 as compared to Rs.172.008 crores during the 9 Months period ended December 31, 2023.

The company has posted net profit / (loss) of Rs.48.778 crores for the 9 Months period ended December 31, 2024 as against net profit / (loss) of Rs.18.914 crores for the 9 Months period ended December 31, 2023.

The company has reported EPS of Rs.7.26 for the 9 Months period ended December 31, 2024 as compared to Rs.2.86 for the 9 Months period ended December 31, 2023.

Financials	9 Months Ended FY2025	9 Months Ended FY2024	% Change
Total Income	₹215.576 crs	₹172.008 crs	25.33%
Net Profit	₹48.778 crs	₹18.914 crs	157.89%
EPS	₹7.26	₹2.86	153.85%